Tatva Chintan Pharma Chem Limited — Others, 01-07-2025: Disclosure under SEBI Takeover Regulations

Tatva Chintan Pharma Chem’s promoter group, including Shekhar Rasiklal Somani, has confirmed that no encumbrance of the company’s shares was created, directly or indirectly, during the last financial year. This reassures shareholders about the promoter group’s commitment and that the shares remain free from any third-party claims or liens, supporting transparency and stability in the company’s shareholding structure.